Some physicians in the US state of Maine will be getting licenses toprescribe medicines in Canada, under a program announced by Allied Healthcare Systems of Maine to try to reduce the cost of prescription drugs. The program calls for a new company to be set up, owned equally by AHS, a for-profit subsidiary of Eastern Maine Healthcare, and a Canadian pharmacy.
AHS will install a computer system and appropriate electronic infrastructure to support the filing of prescriptions from the USA.
AHS has an agreement in principle with a Canadian pharmacy for the joint venture, according to the company's chief operating officer, Miles Theeman, who noted that there is no reason why Maine customers should have to take a bus to Canada to take advantage of the less expensive medicines across the border. AHS has done extensive research into the laws and logistics, he said, and it feels that the plan will work for Mainers. Some physicians in Maine have already become licensed in Canada.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze